Document Detail

Panobinostat shows efficacy in hodgkin lymphoma.
MedLine Citation:
PMID:  22684466     Owner:  NLM     Status:  In-Data-Review    
Panobinostat monotherapy is active against relapsed or refractory Hodgkin lymphoma.
Related Documents :
9707336 - Evolution to malignancy in a recurrent meningioma: morphological and cytogenetic findings.
19955006 - Grade is an independent prognostic factor for feline mammary carcinomas: a clinicopatho...
446506 - Histological grading of transitional cell tumours of the bladder. value of histological...
9252716 - Prognostic significance of proliferating cell nuclear antigen expression in transitiona...
9491666 - Results of treatment in endometrial carcinoma: ten years experience.
25314936 - The transcriptomic profile of ovarian cancer grading.
Publication Detail:
Type:  Journal Article     Date:  2012-05-10
Journal Detail:
Title:  Cancer discovery     Volume:  2     ISSN:  2159-8290     ISO Abbreviation:  Cancer Discov     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-06-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101561693     Medline TA:  Cancer Discov     Country:  United States    
Other Details:
Languages:  eng     Pagination:  OF8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  T Cells Targeting NY-ESO-1 and Melan-A Are Prognostic in Melanoma.
Next Document:  ?-Catenin Inhibition Synergizes with Imatinib to Delay CML Recurrence.